Clinical Study of Caffeine for Apnea of Prematurity
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The aim of the present Phase III study is to evaluate the safety, efficacy and
pharmacokinetics of Caffeine Citrate for treatment of apnea of prematurity in Japan.